BioLife Solutions, Inc. (BLFS)
36.37
-0.83
(-2.23%)
USD |
NASDAQ |
Aug 28, 16:00
36.39
+0.02
(+0.05%)
After-Hours: 20:00
BioLife Solutions Cash from Operations (Quarterly) : 6.348M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.348M |
| March 31, 2026 | -0.491M |
| December 31, 2025 | 4.916M |
| September 30, 2025 | 6.104M |
| June 30, 2025 | 7.368M |
| March 31, 2025 | 1.727M |
| December 31, 2024 | 1.645M |
| September 30, 2024 | 4.802M |
| June 30, 2024 | 6.459M |
| March 31, 2024 | -4.475M |
| December 31, 2023 | 2.311M |
| September 30, 2023 | -4.379M |
| June 30, 2023 | -7.718M |
| March 31, 2023 | -2.712M |
| December 31, 2022 | 7.857M |
| September 30, 2022 | 1.496M |
| June 30, 2022 | -9.917M |
| March 31, 2022 | -7.924M |
| December 31, 2021 | -0.774M |
| September 30, 2021 | 2.083M |
| June 30, 2021 | -7.722M |
| March 31, 2021 | 1.82M |
| December 31, 2020 | 2.257M |
| September 30, 2020 | -0.502M |
| June 30, 2020 | 4.203M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.687M |
| December 31, 2019 | -1.003M |
| September 30, 2019 | 1.137M |
| June 30, 2019 | -0.067M |
| March 31, 2019 | 1.146M |
| December 31, 2018 | 0.5855M |
| September 30, 2018 | 0.8092M |
| June 30, 2018 | 0.5617M |
| March 31, 2018 | 0.3916M |
| December 31, 2017 | 0.803M |
| September 30, 2017 | 0.0744M |
| June 30, 2017 | -0.1029M |
| March 31, 2017 | -0.1693M |
| December 31, 2016 | -0.6681M |
| September 30, 2016 | -0.8837M |
| June 30, 2016 | -1.182M |
| March 31, 2016 | -1.594M |
| December 31, 2015 | -1.270M |
| September 30, 2015 | -1.169M |
| June 30, 2015 | -1.227M |
| March 31, 2015 | -1.308M |
| December 31, 2014 | -0.6968M |
| September 30, 2014 | -0.6979M |
| June 30, 2014 | -0.8735M |
| March 31, 2014 | -0.8941M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Repligen Corp. | 32.77M |
| Agilent Technologies, Inc. | 519.00M |
| Danaher Corp. | 1.534B |
| Thermo Fisher Scientific, Inc. | 2.125B |
| West Pharmaceutical Services, Inc. | 124.00M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -1.579M |
| Cash from Financing (Quarterly) | -3.594M |
| Free Cash Flow | 7.987M |
| Free Cash Flow Per Share (Quarterly) | 0.1052 |
| Free Cash Flow to Equity (Quarterly) | 4.304M |
| Free Cash Flow to Firm (Quarterly) | 5.185M |
| Free Cash Flow Yield | 0.45% |